Patents
Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
06/2000
06/20/2000US6077976 Process for recovery of aminoalcohols from aqueous solutions containing inorganic salts
06/15/2000WO2000006531A3 Nitric esters and nitrate salts of specific drugs
06/15/2000DE19857475A1 Substituierte Cycloheptene, deren Herstellung und Verwendung Substituted cycloheptenes, their preparation and use
06/14/2000EP1008342A2 Pharmaceutically active compounds and liposomes, and methods of use thereof
06/14/2000EP0823892B1 Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma
06/13/2000US6075168 Selective production of diethanolamine
06/08/2000WO2000032557A1 Novel 3-alkoxybenzylamine derivatives and their use as medicines for treating schizophrenia
06/08/2000WO2000032556A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same
06/08/2000WO2000032555A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same
06/08/2000WO2000032553A1 Method for purifying triethanolamine
06/08/2000DE19855383A1 Verfahren zur Reinigung von Triethanolamin A method of purifying triethanolamine
06/08/2000CA2354158A1 Novel 3-alkoxybenzylamine derivatives and their use as medicines for treating schizophrenia
06/08/2000CA2352321A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same
06/07/2000EP1006104A1 P-aminophenol substitute and its use in oxidation dye formulations
06/07/2000EP1006102A2 Aniline derivative and process for producing the same
06/07/2000CN1255919A Efficient enantioselective addition reaction using organozinc reagent
06/07/2000CN1255490A Optical decomposing process of 2-amino-2'-hydroxyl-1,1'-dinaphthalene
06/06/2000US6071971 For treating pulmonary disorders
06/06/2000US6071970 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
05/2000
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/30/2000USRE36718 Optically active aminoalcohol derivatives and method of producing same
05/30/2000US6069177 3-Hydroxy-propanamine derived neuronal reuptake inhibitors
05/30/2000US6069176 Phenylethanolamine compounds with a beta-3 adrenergic receptor stimulating effect, use as a therapy for urinary incontinence
05/24/2000EP1002792A1 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same
05/24/2000EP1002790A1 Sphingosine analogues
05/24/2000CN1052716C Elemene hydroxyls derivs. and their use as anticancer drugs
05/18/2000WO2000027798A1 Production of 2-amino-2-[2-(4-c2-20-alkyl-phenyl)ethyl]propane-1,3-diols
05/18/2000WO2000027795A1 Transfection reagents
05/18/2000WO2000027780A1 Methods and compositions for inhibiting polymerization of ethylenically unsaturated hydrocarbons
05/17/2000EP0873298A4 Chiral reductions of imines leading to the syntheses of optically active amines
05/17/2000CN1253555A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/17/2000CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
05/16/2000US6063965 Production of diethanolamine
05/16/2000US6063964 5-hydroxymethyl-2-aminotetralins as cardiovascular agents
05/16/2000US6063963 Amino acid-derived diaminopropanols
05/16/2000US6063921 Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines
05/10/2000EP0999203A1 Novel developer in oxidative hair dyeing
05/10/2000EP0998448A1 Novel n-alkyl-hydroxybenzylamines, preparation method, uses and compositions containing them
05/10/2000CN1052240C Method for preparing inhibitor of retroinfection viral protease
05/09/2000US6060503 Antiestrogenic, anticarcinogenic stereospecific benzopyran derivative; breast cancer
05/09/2000US6060455 Cationic and polycationic amphiphiles, reactives containing the same and their use
05/04/2000WO2000024510A1 Combinatorial approach to chiral reagents or catalysts having amine or amino alcohol ligands
05/04/2000WO2000024405A1 Compounds and their therapeutic use with diabetic complications
05/04/2000WO2000006658A3 Adhesives and sealants
05/04/2000WO1999064038A9 Novel analgesic agents
05/04/2000WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS
05/04/2000CA2348844A1 Compounds and their therapeutic use with diabetic complications
05/03/2000EP0997459A1 Intermediates for preparing retroviral protease inhibiting compounds
05/03/2000EP0997453A1 Phenoxyisobutyric acid ammonium salts and pharmaceutical formulations containing them
05/03/2000EP0833813B1 Concentrated solutions of polyhydroxy alkyl amines and their use, especially for producing polyhydroxy alkyl carboxylic acid amides
05/03/2000CA2287821A1 Novel primary intermediate in oxidative hair dyeing
05/02/2000US6057479 Multistage reaction of hydroxy indanone with amine to form imine, heating and hydrogenation
05/02/2000US6057371 Sigma receptor ligands and the use thereof
05/02/2000US6057369 Use in the treatment of disease states associated with proteins that mediate cellular activity which are capable of being modulated by inhibiting a matrix metalloproteinase (mmp), tumor necrosis factor (tnf) or cyclic amp
04/2000
04/27/2000WO2000006137A3 Glucocorticoid-selective anti-inflammatory agents
04/27/2000WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors
04/26/2000EP0994884A1 Diphosphonic acid salts for the treatment of osteoporosis
04/26/2000CN1251582A Asymmetric synthesis of benzoxazinones via new intermediates
04/26/2000CN1251569A Noval compounds, their use and preparation
04/26/2000CN1251521A Compound and method for therapeutic intervention in preventing diabetic complications
04/26/2000CN1051759C Process for preparing arylethanolamine
04/25/2000US6054617 Nitro compound-reducing process
04/25/2000US6054593 Elastase inhibitor
04/25/2000US6054474 Activating opioid receptors
04/21/2000CA2286646A1 Process and intermediates for preparing nicotinamide derivatives
04/20/2000WO2000021941A1 Biomimetic chelating agents and methods
04/20/2000WO2000021910A2 1,2-disubstituted cyclopropanes
04/20/2000WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors
04/20/2000CA2347092A1 1,2-disubstituted cyclopropanes
04/19/2000EP0993437A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
04/19/2000EP0730570B1 Method for making intermediates useful in synthesis of retroviral protease inhibitors
04/18/2000US6051719 Dibenzorhodamine dyes
04/18/2000US6051610 Compounds useful as neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics
04/11/2000US6048889 Proline derivatives
04/11/2000US6048882 Isoprenylamine compound
04/06/2000WO2000018724A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
04/06/2000WO2000018723A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/06/2000WO2000018721A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/06/2000WO1999062505A3 Method for treating neurodegenerative disorders
04/06/2000WO1999050205A3 Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
04/06/2000WO1999037294A3 Mitochondria protecting agents for treating mitochondria associated diseases
04/06/2000CA2345108A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/05/2000EP0868397B1 Stabilised hydroxylamine solutions
04/05/2000EP0854856B1 Nitro compound-reducing process
04/05/2000EP0842140B1 Process for the hydrogenation of imines
04/05/2000EP0821664B1 Method for producing aminoethylethanolamine and/or hydroxyethyl piperazine
04/04/2000US6046361 Polyorganofullerenes
04/04/2000US6046359 Catalysts for the amination of alkylene oxides, alcohols, aldehydes and ketones
04/04/2000CA1340948C Peptidylaminodiols
04/04/2000CA1340940C Peptidylaminodiols
03/2000
03/30/2000WO2000017133A2 Lta4 hydrolase inhibitors
03/29/2000EP0989113A1 Processes for producing 2-aminomalonic acid derivatives and 2-amino-1,3-propanediol derivatives, and intermediates for producing the derivatives
03/29/2000EP0988278A1 Preparation and uses of n-methylnitrone
03/29/2000CN1248574A Processfor stabilizing 4,6-diamino resorcinol and salt thereof
03/29/2000CN1248439A Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system
03/28/2000US6043300 Liquid rheological additives for non-aqueous systems and non-aqueous systems containing such liquid rheological additives
03/23/2000WO2000015600A2 Process for production of 2-amino-1,3-propanediol
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000CA2342215A1 Process for production of 2-amino-1,3-propanediol
03/22/2000EP0986527A1 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 116